ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Clinical trial NCT07038096 · RECRUITING
Trial details
- NCT number
- NCT07038096
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-23
- Primary completion
- 2027-09-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.